Smith & Nephew (NYSE:SNN) saw its $4.7 million patent infringement victory over Arthrex overturned in federal appeals court Monday.
MicroAire Surgical Instruments LLC settled a patent infringement and breach of contract lawsuit with Arthrex Inc. involving minimally invasive treatment for carpal tunnel syndrome.
ConMed Corp. is suing a former sales rep and rival Champion Orthopaedics Inc., alleging that they conspired to poach customers from the University of Massachusetts hospital system.
A federal judge in Texas handed Smith & Nephew (NYSE:SNN) a mixed blessing in its ongoing patent infringement fracas with Arthrex Inc., granting an injunction against further infringement but giving Arthrex a stay pending appeal.
A jury in Texas ruled that Arthrex Inc. infringed a patent held by Smith & Nephew Inc. (NYSE:SNN) and awarded a $4.7 million judgment to the British medical device giant.
Smith & Nephew’s Andover, Mass.-based endoscopy division sued Naples, Fla.-based Arthrex in 2007 in the United States District Court for Eastern Texas, accusing it of violating a pair of patents covering techniques for attaching anterior cruciate ligament grafts to bone. The companies agreed to dismiss the charges relating to one of the patents, according to court documents, but allowed a jury to decide about the other patent.